These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6689220)

  • 1. [Platelet serology and Glanzmann's disease].
    Ribera A; Martín-Vega C; Picó M; Massuet L; Argelagués E; Julia A; López A; Tusell J; Triginer J
    Sangre (Barc); 1983; 28(4):456-62. PubMed ID: 6689220
    [No Abstract]   [Full Text] [Related]  

  • 2. Lek a, a new platelet antigen absent in Glanzmann's thrombasthenia.
    Boizard B; Wautier JL
    Vox Sang; 1984; 46(1):47-54. PubMed ID: 6702141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossed immunoelectrophoresis of human platelet membranes. Diminished major antigen in Glanzmann's thrombasthenia and Bernard-Soulier syndrome.
    Shulman S; Karpatkin S
    J Biol Chem; 1980 May; 255(9):4320-7. PubMed ID: 7372679
    [No Abstract]   [Full Text] [Related]  

  • 4. Probable genetic linkage between genes coding for platelet-specific antigens of the PlA and Bak systems.
    Letellier SJ; Hunter JB; Aster RH
    Am J Hematol; 1988 Nov; 29(3):139-43. PubMed ID: 3189308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombocyte antigens and thrombocyte antibodies].
    Mueller-Eckhardt C
    Med Welt; 1967 Jan; 4():205-9. PubMed ID: 4867767
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet-factor-3 availability in a patient with Glanzmann's disease.
    Inceman S; Tangun Y
    Lancet; 1968 Aug; 2(7564):412. PubMed ID: 4173817
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of platelet-specific alloantigens in Glanzmann's thrombasthenia.
    van Leeuwen EF; von dem Borne AE; von Riesz LE; Nijenhuis LE; Engelfriet CP
    Blood; 1981 Jan; 57(1):49-54. PubMed ID: 6160888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of the First Canadian Workshop on Platelet Serology.
    Décary F
    Curr Stud Hematol Blood Transfus; 1986; (52):6-17. PubMed ID: 3754504
    [No Abstract]   [Full Text] [Related]  

  • 9. Report on the Second Canadian Workshop on Platelet Serology.
    Décary F
    Curr Stud Hematol Blood Transfus; 1988; (54):1-12. PubMed ID: 2894919
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of platelet abnormalities in uremia with and without Glanzmann's thrombasthenia.
    Nomura S; Hamamoto K; Kawakatsu T; Kido H; Yamaguchi K; Fukuroi T; Suzuki M; Yanabu M; Shouzu A; Nishikawa M
    Nephron; 1994; 68(4):442-8. PubMed ID: 7870229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal embolisation in Glanzmann's thrombasthenia.
    van Leeuwen EF; von dem Borne AE
    Br Med J; 1980 Dec; 281(6254):1569. PubMed ID: 7437885
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory and activating human antiplatelet antibodies.
    Deckmyn H; Vanhoorelbeke K; Peerlinck K
    Baillieres Clin Haematol; 1998 Jun; 11(2):343-59. PubMed ID: 10097812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endogenous lectin of human platelets is an alpha-granule component.
    Gartner TK; Gerrard JM; White JG; Williams DC
    Blood; 1981 Jul; 58(1):153-7. PubMed ID: 7236887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the platelet-specific alloantigen PlA1 from platelets in Glanzmann's thrombasthenia.
    Kunicki TJ; Aster RH
    J Clin Invest; 1978 May; 61(5):1225-31. PubMed ID: 566280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inheritance of the human platelet alloantigen, PlA1, in type I Glanzmann's thrombasthenia.
    Kunicki TJ; Pidard D; Cazenave JP; Nurden AT; Caen JP
    J Clin Invest; 1981 Mar; 67(3):717-24. PubMed ID: 7193688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in the physiopathology of the platelet membrane (author's transl)].
    Ruan C; Kieffer N; Tobelem G
    Pathol Biol (Paris); 1982 Feb; 30(2):69-72. PubMed ID: 6806766
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of the alloantigen Zwa (or P1A1) on human vascular smooth muscle cells and foreskin fibroblasts: a study on normal individuals and a patient with Glanzmann's thrombasthenia.
    Giltay JC; Brinkman HJ; von dem Borne AE; van Mourik JA
    Blood; 1989 Aug; 74(3):965-70. PubMed ID: 2473812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of autoantibodies in autoimmune thrombocytopenia.
    van Leeuwen EF; van der Ven JT; Engelfriet CP; von dem Borne AE
    Blood; 1982 Jan; 59(1):23-6. PubMed ID: 7032627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood platelet-specific antigens and antibodies. Clinical significance in blood platelet deficiency in neonates and after transfusion].
    Nordhagen R; Kornstad L
    Tidsskr Nor Laegeforen; 1985 Apr; 105(11):746-8. PubMed ID: 2409616
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of the binding of anti-Zwa antibodies on platelet function.
    van Leeuwen EF; Leeksma OC; van Mourik JA; Engelfriet CP; von dem Borne AE
    Vox Sang; 1984; 47(4):280-9. PubMed ID: 6548327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.